|TNBI -- USA Stock|| |
USD 0.03 0.005 20.00%
VP of RandD
Dr. Xugang Shu is Vice President Research Development of Tanke Biosciences Corp
Age: 34 VP Since 2011
86 20 3885 9025 http://www.tanke-bio.com
Shu joined Guangzhou Tanke in 2002 after receiving his Masters Degree in Chemistry from Guangdong University of Technology. From December 2002 until December 2004, he was in charge of Guangzhou Tanke?s product quality meeting ISO 9001 and 2000 standards and compliance with GMP. In 2005, Dr. Shu became Guangzhou Tanke?s Vice President for Research & Development and organized the technology research center that was responsible for 12 patent applications. He has received numerous awards and received a PhD in Chemistry from Guangdong University of Technology.
The company has return on total asset (ROA)
of (0.12) %
which means that it has lost $0.12 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (10.39) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 9.5 M in liabilities with Debt to Equity (D/E) ratio of 60.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Tanke Biosciences Corporation has Current Ratio of 1.58 which is within standard range for the sector.
Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. Tanke Biosciences operates under Packaged Foods classification in USA and traded on OTC Market. It employs 130 people.Tanke Biosciences Corporation (TNBI) is traded on OTC Market in USA. It is located in East Tower of Hui Hao Building and employs 130 people.
Tanke Biosciences Management Team
Stock Performance Indicators